Sat, Dec 27, 2014, 11:38 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Biogen Idec Inc. Message Board

me527 2 posts  |  Last Activity: Mar 28, 2013 8:32 PM Member since: Mar 14, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • me527@ymail.com by me527 Mar 28, 2013 8:32 PM Flag

    My wife has MS. So i am very aware of the costs and different therapies and their pros and cons. BG-12 is the most talked about therapy for MS patients. The shots hurt and are not as effective as BG-12. I attended a rebif sponsered dinner last month and the hottest and most talked about topic was BG-12. Patients want it badly. This drug will dominate the market like no other oral medication. Gelenia takes a ton of testing to get on and if you have to come off of it for any reason you have to begin the testing on it all over again. Real pain in the #$%$ BG-12 will dominate all MS meds in the next few years.

  • me527@ymail.com by me527 Mar 14, 2011 9:03 PM Flag

    Ok Japan had a bad day. This does not change any policy in china, france, england, or india. THese countries are going to "reevaluate" which means no other choices but nuclear, any tsumani's in my country... Check!! Keep on building boys!! And if AMerica stops their building boom on nuclear power...what building boom? AMerica has been out of Nuke plants for 30 years. Believe me i know I am in the nuke industry, the job market is awesome, you cant keep an engineer right now the market is so hot. So take this as an opportunity to buy!!! I did

BIIB
342.40+1.51(+0.44%)Dec 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.